Cargando…
Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
BACKGROUND: Ulcerative colitis (UC) is a chronic relapsing disease necessitating lifelong treatment. Most patients present with mild-to-moderate disease characterized by alternating periods of remission and clinical relapse. Continued disease progression and relapse of UC overtime are associated wit...
Autores principales: | Tindall, William N., Boltri, John M., Wilhelm, Sheila M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437681/ https://www.ncbi.nlm.nih.gov/pubmed/17874873 http://dx.doi.org/10.18553/jmcp.2007.13.s7-a.2 |
Ejemplares similares
-
The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis
por: Kane, Sunanda V., et al.
Publicado: (2008) -
Efficacy of JAK inhibitors in Ulcerative Colitis
por: Ferrante, Marc, et al.
Publicado: (2020) -
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020) -
Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022) -
JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020)